HOME > Projects > Immunopharmaceutical Development Unit

B-16

Immunopharmaceutical Development Unit

7F

0709

Next-generation digital biomarker for early diagnosis of dementia

Rapid increase in dementia cases is becoming a serious social issue worldwide. Recent literature suggests that early diagnosis and interventions can prevent dementia progression or onset. This highlights the need for more efficient and convenient diagnostic tools to address the worldwide dementia epidemic. We developed a novel screening test for dementia using an eye-tracking technology (eye-tracking-based cognitive assessment, ETCA) and demonstrated its utility in clinical settings. We are going to further improve its performance and expand our project worldwide.

Responsible Departments

Department of Clinical Gene Therapy

Research Partner

Ai-BrainScience Inc.

Project Members

Principal Investigator

MORISHITA Ryuichi

Endowed Chair Professor

Department of Clinical Gene Therapy

 

TAKEDA Shuko

Endowed Chair Associate Professor

Department of Clinical Gene Therapy

←back